Document is current

Any future updates will be listed below

Rituximab, tacrolimus, cyclophosphamide and cyclosporin in primary membranous nephropathy with nephrotic syndrome: comparison of safety profiles, effect on remission rate, 24-h urinary total protein, serum albumin, and serum creatinine levels using network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s11255-025-04549-4

Published Online: 2025-05-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark